rs794727855
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001849.4(COL6A2):c.875G>T(p.Gly292Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G292D) has been classified as Pathogenic.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.875G>T | p.Gly292Val | missense_variant | 7/28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.875G>T | p.Gly292Val | missense_variant | 7/28 | NP_478054.2 | ||
COL6A2 | NM_058175.3 | c.875G>T | p.Gly292Val | missense_variant | 7/28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.875G>T | p.Gly292Val | missense_variant | 7/28 | 1 | NM_001849.4 | ENSP00000300527.4 | ||
COL6A2 | ENST00000397763.6 | c.875G>T | p.Gly292Val | missense_variant | 7/28 | 5 | ENSP00000380870.1 | |||
COL6A2 | ENST00000409416.6 | c.875G>T | p.Gly292Val | missense_variant | 6/27 | 5 | ENSP00000387115.1 | |||
COL6A2 | ENST00000485591.1 | n.531G>T | non_coding_transcript_exon_variant | 3/7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1450496Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 720858
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 29, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Feb 08, 2021 | PS2, PS4_Moderate, PM6_strong, PM1 - |
Bethlem myopathy 1A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 21, 2021 | For these reasons, this variant has been classified as Pathogenic. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL6A2, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 15689448, 24038877) compared to the general population (ExAC). This variant has been observed to be de novo in several individuals affected with congenital muscular dystrophy (PMID: 17785673, 24038877). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with valine at codon 292 of the COL6A2 protein (p.Gly292Val). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and valine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at